Aurum Biosciences
a
M

About us

Our team

Our science

News

Pipeline

Investors

Contact

  • Home
  • About us
  • Our Team
  • Our Science
  • News
  • Pipeline
  • Investors
  • Contact us

Scottish leader in innovative stroke technology invited to share global insights at premier London gathering

by David Brennan | May 25, 2026 | News

World-leading innovator in stroke treatment to discuss vital investment insights at London gathering

by David Brennan | Mar 3, 2026 | News

Aurum Biosciences has been selected to showcase world-leading stroke technology through UK trade mission to India

by David Brennan | Feb 10, 2026 | News

Aurum Biosciences set to showcase world-leading stroke technology at US healthcare week

by David Brennan | Jan 9, 2026 | News

Aurum Biosciences aiming to further accelerate growth with Boston Congress presence

by David Brennan | Sep 11, 2025 | News

Aurum Biosciences has been invited to speak at a flagship life sciences conference in the US, further fostering its growth ambitions Aurum Biosciences which is a spinout of NHS Greater Glasgow and Clyde, InnoScot Health, and the University of Glasgow, is a...
« Older Entries

Recent Posts

  • Scottish leader in innovative stroke technology invited to share global insights at premier London gathering
  • World-leading innovator in stroke treatment to discuss vital investment insights at London gathering
  • Aurum Biosciences has been selected to showcase world-leading stroke technology through UK trade mission to India
  • Aurum Biosciences set to showcase world-leading stroke technology at US healthcare week
  • Aurum Biosciences aiming to further accelerate growth with Boston Congress presence

Recent Comments

No comments to show.

Revolutionising patient pathways to deliver better
outcomes for more patients

dbrennan@aurumbiosciences.com
Tel: +44 (0)7711 780005

Aurum Biosciences Ltd
Imaging Centre of Excellence
Queen Elizabeth University Hospital Campus,
Langlands Drive, Glasgow, G51 4LB

About us | Our team | Our Science | News | Pipeline | Investors | Contact